Smoking Cessation in a Cohort HIV+ Rio de Janeiro, Brazil.

Instituto Fernandes Figueira

Status

Completed

Conditions

Brachial Flow Mediated Dilatation

Nicotine Replacement Therapy

Smoking Cessation

Treatments

Drug: Nicotine replacement

Study type

Observational

Funder types

Other

Identifiers

NCT05873738

3.171.692

Details and patient eligibility

About

The study was carried out within a large, urban prospective cohort of PLHIV at the Instituto Nacional de Infectologia Evandro Chagas (INI). Located in Rio de Janeiro, Brazil, INI is a national public referral center for PLWHA receiving primary care since 1998. From December 2019, adults who had attitudes toward quitting smoking and had no contraindications to study pharmacotherapy were enrolled by active site searching

Enrollment

115 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

individuals were deemed as regular smokers, defined as the consumption of one or more pack (20 cigarettes) per week in the past 6 months, and expired carbon monoxide (CO) measurement > 10 ppm at the screening visit.

Exclusion criteria

previous use of transdermal nicotine patches or bupropion in the last 6 months; (ii) contraindication to nicotine patches; (iii). Pregnancy; (iv) breastfeeding